$NAOV
NanoVibronix, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224045726 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $376.0K
YoY Change -17.9%
Cost Of Revenue $243.0K
YoY Change 122.94%
Gross Profit $133.0K
YoY Change -61.89%
Gross Profit Margin 35.37%
Selling, General & Admin $854.0K
YoY Change -13.39%
% of Gross Profit 642.11%
Research & Development $249.0K
YoY Change 654.55%
% of Gross Profit 187.22%
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $1.103M
YoY Change 8.24%
Operating Profit -$970.0K
YoY Change 44.78%
Interest Expense $33.00K
YoY Change -5.71%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$995.0K
YoY Change 37.43%
Income Tax $3.000K
% Of Pretax Income
Net Earnings -$998.0K
YoY Change 37.28%
Net Earnings / Revenue -265.43%
Basic Earnings Per Share -$0.36
Diluted Earnings Per Share -$0.36
COMMON SHARES
Basic Shares Outstanding 3.752M shares 2.784M shares
Diluted Shares Outstanding 2.803M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.305M
YoY Change -65.57%
Cash & Equivalents $1.305M
Short-Term Investments
Other Short-Term Assets $242.0K
YoY Change 42.35%
Inventory $2.250M
Prepaid Expenses
Receivables $580.0K
Other Receivables $0.00
Total Short-Term Assets $4.377M
YoY Change -38.94%
LONG-TERM ASSETS
Property, Plant & Equipment $9.000K
YoY Change 28.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $305.0K
YoY Change 58.03%
TOTAL ASSETS
Total Short-Term Assets $4.377M
Total Long-Term Assets $305.0K
Total Assets $4.682M
YoY Change -36.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.00K
YoY Change -59.68%
Accrued Expenses $49.00K
YoY Change 145.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.521M
YoY Change 5.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $289.0K
YoY Change 3.21%
Total Long-Term Liabilities $289.0K
YoY Change 3.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.521M
Total Long-Term Liabilities $289.0K
Total Liabilities $2.810M
YoY Change 5.2%
SHAREHOLDERS EQUITY
Retained Earnings -$68.37M
YoY Change 4.73%
Common Stock $3.000K
YoY Change 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.872M
YoY Change
Total Liabilities & Shareholders Equity $4.682M
YoY Change -36.39%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$998.0K
YoY Change 37.28%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$836.0K
YoY Change 22.94%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.00K
YoY Change -100.64%
NET CHANGE
Cash From Operating Activities -836.0K
Cash From Investing Activities 0.000
Cash From Financing Activities -27.00K
Net Change In Cash -863.0K
YoY Change -124.45%
FREE CASH FLOW
Cash From Operating Activities -$836.0K
Capital Expenditures $0.00
Free Cash Flow -$836.0K
YoY Change 22.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36445
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0801232
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77569
dei City Area Code
CityAreaCode
(914)
dei Local Phone Number
LocalPhoneNumber
233-3004
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NAOV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
557000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
181000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Registrant Name
EntityRegistrantName
NanoVibronix, Inc
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1106000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
109000 usd
us-gaap Cost Of Revenue
CostOfRevenue
889000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
133000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001326706
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2024Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
NAOV Stock Issued During Period Values Reverse Stock Splits
StockIssuedDuringPeriodValuesReverseStockSplits
shares
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address Address Line1
EntityAddressAddressLine1
969 Pruitt Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Tyler
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3752354 shares
CY2024Q3 us-gaap Cash
Cash
1305000 usd
CY2023Q4 us-gaap Cash
Cash
3283000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
580000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
318000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
242000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
154000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2250000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2732000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
4377000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6487000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1000 usd
CY2024Q3 NAOV Severance Assets Noncurent
SeveranceAssetsNoncurent
170000 usd
CY2023Q4 NAOV Severance Assets Noncurent
SeveranceAssetsNoncurent
174000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
305000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
187000 usd
CY2024Q3 us-gaap Assets
Assets
4682000 usd
CY2023Q4 us-gaap Assets
Assets
6674000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
25000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
138000 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2420000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2265000 usd
CY2024Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
27000 usd
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
46000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2521000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2454000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
212000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
217000 usd
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
15000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2810000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2686000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2784353 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2784353 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2046307 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2046307 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70314000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70149000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-75000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-67000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68370000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66096000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1872000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3988000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4682000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6674000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
376000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2114000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
243000 usd
us-gaap Cost Of Revenue
CostOfRevenue
306000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
349000 usd
us-gaap Gross Profit
GrossProfit
1225000 usd
us-gaap Gross Profit
GrossProfit
800000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
249000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
123000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
190000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
545000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
631000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
673000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
796000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2335000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2780000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1103000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1019000 usd
us-gaap Operating Expenses
OperatingExpenses
3437000 usd
us-gaap Operating Expenses
OperatingExpenses
3534000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-970000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-670000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2212000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2734000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
33000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
35000 usd
us-gaap Interest Expense
InterestExpense
101000 usd
us-gaap Interest Expense
InterestExpense
102000 usd
CY2024Q3 NAOV Financial Income Expenses Net
FinancialIncomeExpensesNet
8000 usd
CY2023Q3 NAOV Financial Income Expenses Net
FinancialIncomeExpensesNet
-19000 usd
NAOV Financial Income Expenses Net
FinancialIncomeExpensesNet
53000 usd
NAOV Financial Income Expenses Net
FinancialIncomeExpensesNet
-44000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-995000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-724000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2260000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2880000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-998000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-727000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2274000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2898000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2803181 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2803181 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1721026 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1721026 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2712836 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2712836 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1678684 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1678684 shares
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-998000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-727000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2274000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2898000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1001000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-726000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2282000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2934000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3988000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
165000 usd
NAOV Stock Issued During Period Value Prefunded Warrants Exercised
StockIssuedDuringPeriodValuePrefundedWarrantsExercised
1000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2274000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1872000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3233000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3233000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
169000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4215000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000 usd
NAOV Stock Issued During Period Value Prefunded Warrants Exercised
StockIssuedDuringPeriodValuePrefundedWarrantsExercised
7000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2898000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4690000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4690000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2274000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2898000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
165000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
169000 usd
NAOV Noncash Interest Expense
NoncashInterestExpense
100000 usd
NAOV Noncash Interest Expense
NoncashInterestExpense
102000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-1000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
88000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-542000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-482000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1004000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-113000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-4000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
54000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
61000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-34000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-55000 usd
NAOV Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
-1000 usd
NAOV Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
-3000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1968000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3111000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4215000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4222000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-36000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1978000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1074000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3283000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2713000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1305000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3787000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_zwk1U7ldVS2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_827_zDJy2RbcEof3">DESCRIPTION OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix, Inc. (the “Company”), a Delaware corporation, commenced operations on October 20, 2003 and is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy and can be administered at home without the assistance of medical professionals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s principal research and development activities are conducted in Israel through its wholly owned subsidiary, NanoVibronix (Israel 2003) Ltd., a company registered in Israel, which commenced operations in October 2003.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zR4QHrZV6rJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zMk71CPUOYe">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
3000 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
8000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
1000 usd
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
36000 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
709601 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
580000 usd
NAOV Change In Current Expected Credit Losses
ChangeInCurrentExpectedCreditLosses
0 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
11000 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
41000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
26000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
90000 usd
us-gaap Depreciation
Depreciation
1000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
311000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
210000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1939000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2522000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2250000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2732000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
15726 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7828879 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8898114 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7828879 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8898114 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
376000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2114000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1106000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
376000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
458000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2114000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1106000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M4D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
58000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
58000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
14000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
60000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
58000 usd
CY2024Q3 NAOV Lessee Operating Lease Liability Payments Due After Year Two
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo
10000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
142000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
126000 usd
CY2024Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
3000 usd
CY2024Q3 NAOV Increase Decrease In Termination Value By Offset
IncreaseDecreaseInTerminationValueByOffset
1000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1000 usd
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2000 usd
CY2023Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
2000 usd
CY2021Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
3000000 usd
CY2022Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1500250 usd
CY2022Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
1432000 usd
CY2022Q1 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
68250 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
0 usd
us-gaap Legal Fees
LegalFees
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
naov-20240930_def.xml Edgar Link unprocessable
0001493152-24-045726-index-headers.html Edgar Link pending
0001493152-24-045726-index.html Edgar Link pending
0001493152-24-045726.txt Edgar Link pending
0001493152-24-045726-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
naov-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
naov-20240930_cal.xml Edgar Link unprocessable
naov-20240930_lab.xml Edgar Link unprocessable
naov-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending